The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a comprehensive cancer centre

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 820-829

  Habbous, Steven ^a   Chu, Karen P ^a   Qiu, Xin ^a   La Delfa, Anthony ^a   Harland, Luke T G ^a   Fadhel, Ehab ^a   Hui, Angela ^a   Perez Ordonez, Bayardo ^b   Weinreb, Ilan ^b   Liu, Fei Fei ^a,c   Waldron, John ^c   O'Sullivan, Brian ^c   Goldstein, David ^d   Xu, Wei ^a   Huang, Shao Hui ^c   Liu, Geoffrey ^a,d  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alcohol; Epidemiology; Head and neck cancer; Human papillomavirus; Multiple imputation; P16; Smoking; Squamous cell carcinoma; Trends

Indexed keywords

PROTEIN P16;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER REGISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEALTH CARE POLICY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLE IMPUTATION; OROPHARYNX CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; TONGUE TUMOR; TONSIL TUMOR; WART VIRUS;

ALCOHOL; EPIDEMIOLOGY; HEAD AND NECK CANCER; HUMAN PAPILLOMAVIRUS; MULTIPLE IMPUTATION; P16; SMOKING; SQUAMOUS CELL CARCINOMA; TRENDS;

ADOLESCENT; ADULT; AGED; CANADA; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TIME FACTORS; YOUNG ADULT;

EID: 84888289957     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.09.011     Document Type: Article

References (48)

1. Forte T., Niu J., Lockwood G.A., Bryant H.E. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009. Cancer Causes Control 2012, 23(8):1343-1348.
2. Johnson-Obaseki S., McDonald J.T., Corsten M., Rourke R. Head and neck cancer in Canada: trends 1992-2007. Otolaryngol Head Neck Surg 2012, 147(1):74-78.
3. Cole L., Polfus L., Peters E.S. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005. PLoS One 2012, 7(3):e32657.
4. Auluck A., Hislop G., Bajdik C., Poh C., Zhang L., Rosin M. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 2010, 116(11):2635-2644.
5. Blomberg M., Nielsen A., Munk C., Kjaer S.K. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. Int J Cancer 2011, 129(3):733-741.
6. Health Canada Canadian Tobacco Use Monitoring System (CTUMS) 2011, Available from http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/_ctums-esutc_prevalence/prevalence-eng.php.
7. Centers for Disease Control and Prevention Trends in current cigarette smoking among high school students and adults, United States, 1965-2010 2011, Available from http://www.cdc.gov/tobacco/data_statistics/tables/trends/cig_smoking/index.htm.
8. Montero P.H., Patel P.D., Palmer F.L., Patel S.G., Shah J.P., Hayes R.B., et al. Changing trends in smoking and alcohol consumption in patients with oral cancer treated at memorial sloan-kettering cancer center from 1985 to 2009. Arch Otolaryngol Head Neck Surg 2012, 138(9):817-822.
9. Nygård M., Aagnes B., Bray F., Møller B., Mork J. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer. Eur J Cancer 2012, 48(9):1341-1346.
10. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92(9):709-720.
11. De Stefani A., Boffano P., Averono G., Ramella A., Pia F., Bongioannini G. Prevalence and characteristics of HPV infection in oropharyngeal cancer. J Craniofac Surg 2013, 24(1):e40-e43.
12. Centers for Disease Control and Prevention (CDC) Human papillomavirus-associated cancers - United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2012, 20(61):258-261.
13. Simard E.P., Ward E.M., Siegel R., Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin 2012, 10.3322/caac.20141.
14. Mehanna H., Beech T., Nicholson T., El-Hariry I., McConkey C., Paleri V., et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2012, 35(5):747-755.
15. Wang X.I., Thomas J., Zhang S. Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma. Ann Diagn Pathol 2012, 16(1):7-12.
16. O'Rorke M.A., Ellison M.V., Murray L.J., Moran M., James J., Anderson L.A. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 2012, 48(12):1191-1201.
17. O'Sullivan B., Huang S.H., Perez-Ordonez B., Massey C., Siu L.L., Weinreb I., et al. Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol 2012, 103(1):49-56.
18. Brotherston D.C., Poon I., Le T., Leung M., Kiss A., Ringash J., et al. Patient preferences for oropharyngeal cancer treatment de-escalation. Head Neck 2012, 35(2):151-159.
19. O'Sullivan B., Huang S.-H., Siu L.L., Waldron J., Zhao H., Perez-Ordonez B., et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013, 31(5):543-550.
20. Mehanna H., Olaleye O., Licitra L. Oropharyngeal cancer - is it time to change management according to human papilloma virus status?. Curr Opin Otolaryngol Head Neck Surg 2012, 20(2):120-124.
21. Mackillop W.J., Zhou Y., Quirt C.F. A comparison of delays in the treatment of cancer with radiation in Canada and the United States. Int J Radiat Oncol Biol Phys 1995, 32(2):531-539.
22. Chesson H.W., Ekwueme D.U., Saraiya M., Watson M., Lowy D.R., Markowitz L.E. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine 2012, 30(43):6016-6019.
23. de Kok I.M., Habbema J.D., van Rosmalen J., van Ballegooijen M. Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness?. Eur J Cancer 2011, 47(3):428-435.
24. Marklund L., Näsman A., Ramqvist T., Dalianis T., Munck-Wikland E., Hammarstedt L. Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer. Cancer Med 2012, 1(1):82-88.
25. Wong K., Huang S.H., O'Sullivan B., Lockwood G., Dale D., Michaelson T., et al. Point-of-care outcome assessment in the cancer clinic: audit of data quality. Radiother Oncol 2010, 95(3):339-343.
26. Habbous S., Chu K.P., Harland L.T., La Delfa A., Fadhel E., Sun B., et al. Validation of a one-page patient-reported Charlson Comorbidity Index questionnaire for upper aerodigestive tract cancer patients. Oral Oncol 2013, 49(5):407-412.
27. Charlson M.E., Pompei P., Ales K.L., MacKenzie.C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
28. Deleyiannis F.W.-B., Thomas D.B., Vaughan T.L., Davis Alcoholism S. Independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst 1996, 88(8):542-549.
29. Shi W., Kato H., Perez-Ordonez B., Pintilie M., Huang S., Hui A., et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 2009, 27(36):6213-6221.
30. Agoston E.S., Robinson S.J., Mehra K.K., Birch C., Semmel D., Mirkovic J., et al. Polymerase chain reaction detection of HPV in squamous carcinoma of the oropharynx. Am J Clin Pathol 2010, 134(1):36-41.
31. Smeets S.J., Hesselink A.T., Speel E.J., Haesevoets A., Snijders P.J., Pawlita M., et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007, 121(11):2465-2472.
32. Graham J.W., Olchowski A.E., Gilreath T.D. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci 2007, 8(3):206-216.
33. Byrd J.K., Wilhoit C.S., Fordham M.T., Reeves T.D., McCrackan T.R., Nguyen S.A., et al. Predicting HPV status in head and neck cancer: the predictive value of sociodemographic and disease characteristics. Arch Otolaryngol Head Neck Surg 2012, 138(12):1155-1159.
34. Klebanoff M.A., Cole S.R. Use of multiple imputation in the epidemiolgic literature. Am J Epidemiol 2008, 168(4):355-357.
35. Croiseau P., Bardel C., Génin E. Efficiency of multiple imputation to test for association in the presence of missing data. BMC Proc. 2007, 1(Suppl. 1):S24.
36. Sterne J.A., White I.R., Carlin J.B., Spratt M., Royston P., Kenward M.G., et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009, 339:157-160.
37. Groenwold R.H., Donders A.R., Roes K.C., Harell F.E., Moons K.G. Dealing with missing outcome data in randomized trials and observational studies. Am J Epidemiol 2012, 175(3):210-217.
38. Rietbergen M.M., Leemans C.R., Bloemena E., Heideman D.A., Braakhuis B.J., Hesselink A.T., et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 2013, 132(7):1565-1571.
39. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2012, 29(32):4294-4301.
40. Drugan C., Leary S., Mellor T., Bain C., Verne J., Ness A., et al. Head and neck cancer in the south west of England, Hampshire, and the Isle of Wight: trends in survival 1996-2008. Br J Oral Maxillofac Surg 2012, 51(1):19-24.
41. de Souza D.L., Curado M.P., Bernal M.M., Jerez-Roig J., Boffetta P. Mortality trends and prediction of HPV-related cancers in Brazil. Eur J Cancer Prev 2013, 22(4):380-387.
42. Forster A.S., Marlow L.A., Wardle J., Stephenson J., Waller J. Interest in having HPV vaccination among adolescent boys in England. Vaccine 2012, 30(30):4505-4510.
43. Alexander K., Daley A.M., Dempsey A.F. Rationale for reducing the spread of human papillomavirus in adolescents: strategies to improve outcomes (CME Multimedia Activity). J Adolesc Health 2012, 50(5):IBC.
44. Rank C., Gilbert M., Ogilvie G., Jayaraman G.C., Marchand R., Trussler T., et al. Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs. Vaccine 2012, 30(39):5755-5760.
45. Low G.M., Attiga Y.S., Garg G., Schlegal R., Gallicano G.I. Can male vaccination reduce the burden of human papillomavirus-related disease in the United States?. Viral Immunol 2012, 25(3):174-186.
46. Brown D.R., Kjaer S.K., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Wheeler C.M., et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis 2009, 199(7):926-935.
47. Marty R., Roze S., Bresse X., Largeron N., Smith-Palmer J. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. BMC Cancer 2013, 10.1186/1471-2407-13-10.
48. Héraud-Bousquet V., Larsen C., Carpenter J.R., Desenclos J.C., Le Strat Y. Practical considerations for sensitivity analysis after multiple imputation applied to epidemiological studies with incomplete data. BMC Med Res Methodol 2012, 10.1186/1471-2288-12-73.